کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5904517 | 1158005 | 2014 | 10 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
S-(â)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
UABFFQSSQER+ - ER +Asian American - آمریکایی آسیاییAfrican American - آمریکاییهای آفریقایی تبار Breast biopsy - بیوپسی پستانPostmenopausal women - زنان پس از یائسگیBreast cancer - سرطان پستانbody mass index - شاخص توده بدنBMI - شاخص توده بدنیconfidence interval - فاصله اطمینانodds ratio - نسبت شانس هاDuctal hyperplasia - هیپرپلازی داکتالFFQ, Food Frequency Questionnaire - پرسشنامه بسامد خوراک، پرسشنامه بسامد مصرف غذاییEstrogen receptor - گیرنده استروژنestrogen receptor positive - گیرنده استروژن مثبت است
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
علوم غدد
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Soy foods are the richest sources of isoflavones, mainly daidzein and genistein. Soy isoflavones are structurally similar to the steroid hormone 17β-estradiol and may protect against breast cancer. S-(â)equol, a metabolite of the soy isoflavone daidzein, has a higher bioavailability and greater affinity for estrogen receptor β than daidzein. Approximately one-third of the Western population is able to produce S-(â)equol, and the ability is linked to certain gut microbes. We hypothesized that the prevalence of breast cancer, ductal hyperplasia, and overall breast pathology will be lower among S-(â)equol producing, as compared with nonproducing, postmenopausal women undergoing a breast biopsy. We tested our hypothesis using a cross-sectional study design. Usual diets of the participants were supplemented with 1 soy bar per day for 3 consecutive days. Liquid chromatography-multiple reaction ion monitoring mass spectrometry analysis of urine from 143 subjects revealed 25 (17.5%) as S-(â)equol producers. We found no statistically significant associations between S-(â)equol producing status and overall breast pathology (odds ratio [OR], 0.68; 95% confidence interval [CI], 0.23-1.89), ductal hyperplasia (OR, 0.84; 95% CI, 0.20-3.41), or breast cancer (OR, 0.56; 95% CI, 0.16-1.87). However, the mean dietary isoflavone intake was much lower (0.3 mg/d) than in previous reports. Given that the amount of S-(â)equol produced in the gut depends on the amount of daidzein exposure, the low soy intake coupled with lower prevalence of S-(â)equol producing status in the study population favors toward null associations. Findings from our study could be used for further investigations on S-(â)equol producing status and disease risk.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Nutrition Research - Volume 34, Issue 2, February 2014, Pages 116-125
Journal: Nutrition Research - Volume 34, Issue 2, February 2014, Pages 116-125
نویسندگان
Mandeep K. Virk-Baker, Stephen Barnes, Helen Krontiras, Tim R. Nagy,